Der Radiologe

, Volume 44, Issue 5, pp 444–456 | Cite as

Radiologische Diagnostik von Hodgkin- und Non-Hodgkin-Lymphomen des Thorax

Maligne Thoraxtumoren: CT und MRT

Zusammenfassung

Lymphomerkrankungen gehören in den westlichen Ländern zu den bedeutenden Malignomen, insbesondere die Non-Hodgkin-Lymphome weisen eine steigende Inzidenz auf. Der Thorax ist der Ort der Primärmanifestation insbesondere beim Hodgkin-Lymphom, eine Progredienz der Erkrankung und therapieassoziierte Komplikationen entwickeln sich bei beiden Lymphomarten häufig intrathorakal. Bildmorphologisch lassen sich die verschiedenen Lymphome nicht unterscheiden, Aufschlüsse geben allerdings die Ausbreitungswege der Erkrankung. Ein primärer oder sekundärer Lungenbefall stellt die Radiologie vor eine differenzialdiagnostische Herausforderung, die Muster sind sowohl im Thoraxübersichtsbild als auch in der CT variabel und unterliegen einem Wandel unter der Therapie. Radiologische Verfahren, insbesondere die CT, sind integraler Bestandteil des Stagings bei Erstmanifestation und Verlaufskontrolle. Die MRT erleichtert die Beurteilung von Thoraxwandlymphomen. Die PET als funktionelles bildgebendes Verfahren hat einen festen Platz in der Diagnostik der hochmalignen Lymphome, die Kombination aus morphologischen und funktionellen Bildern in der PET-CT avanciert zum diagnostischen Standard der Zukunft.

Schlüsselwörter

Hodgkin-Lymphom Non-Hodgkin-Lymphom Thorax Lunge Computertomographie (CT) Magnetresonanztomographie (MRT) Positronenemissionstomographie (PET) 

Radiological diagnosis of thoracic Hodgkin- and Non-Hodgkin lymphomas

Abstract

Malignant lymphomas belong to the most important malignant diseases in western countries with an increasing incidence of Non-Hodgkin lymphoma. The thorax is the location of primary manifestation especially in patients with Hodgkin’s disease. Progression of disease and therapy associated complications are frequently located in the chest.

Based on morphological imaging criteria the two types of lymphoma cannot be differentiated, helpful for differentiation is, however, the way of disease spread. Primary and secondary thoracic lymphoma represent a diagnostic challenge in radiology: the patterns are variable in radiography as well as in computed tomography and alter under therapy.

Radiological studies, especially CT, are an integral part of the staging process. MRI is considered advantageous for chest wall disease. PET as functional imaging technique has its proven role for staging of high grade lymphomas, the combination of functional and morphological information provided by PET-CT will become the first diagnostic standard in the future.

Keywords

Hodgkin’s disease Non-Hodgkin lymphoma Thorax Lung Computed tomography (CT) Magnetic resonance imaging (MRI) Positron-emission tomography (PET) 

Notes

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Literatur

  1. 1.
    Ahmed S, Siddiqui AK, Rai KR (2002) Low-grade B-cell bronchial associated lymphoid tissue (BALT) lymphoma. Cancer Invest 20:1059–1068CrossRefPubMedGoogle Scholar
  2. 2.
    Au V, Leung AN (1997) Radiologic manifestations of lymphoma in the thorax. AJR Am J Roentgenol 168:93–98Google Scholar
  3. 3.
    Auner HW, Sill H, Mulabecirovic A, Linkesch W, Krause R (2002) Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma. Ann Hematol 81:374–377CrossRefPubMedGoogle Scholar
  4. 4.
    Becherer A, Mitterbauer M, Jaeger U, Kalhs P, Greinix HT, Karanikas G, Potzi C, Raderer M, Dudczak R, Kletter K (2002) Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation. Leukemia 16:260–267CrossRefPubMedGoogle Scholar
  5. 5.
    Bergin CJ, Healy MV, Zincone GE, Castellino RA (1990) MR evaluation of chest wall involvement in malignant lymphoma. J Comput Assist Tomogr 14:928–932PubMedGoogle Scholar
  6. 6.
    Bonomo L, Ciccotosto C, Guidotti A, Merlino B, Storto M (1997) Staging of thoracic lymphoma by radiological imaging. Eur Radiol 7:1179–1189PubMedGoogle Scholar
  7. 7.
    Bosanko CM, Korobkin M, Fantone JC, Rubin SB, Lynch JP (1991) Lobar primary pulmonary lymphoma: CT findings. J Comput Assist Tomogr 15:679–682PubMedGoogle Scholar
  8. 8.
    Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the Committee on Hodgkin’s Disease Staging Classification. Cancer Res 31:1860–1861PubMedGoogle Scholar
  9. 9.
    Carignan S, Staples CA, Muller NL (1995) Intrathoracic lymphoproliferative disorders in the immunocompromised patient: CT findings. Radiology 197:53–58PubMedGoogle Scholar
  10. 10.
    Carlsen SE, Bergin CJ, Hoppe RT (1993) MR imaging to detect chest wall and pleural involvement in patients with lymphoma: effect on radiation therapy planning. AJR Am J Roentgenol 160:1191–1195PubMedGoogle Scholar
  11. 11.
    Castellino RA, Blank N, Hoppe RT, Cho C (1986) Hodgkin disease: contributions of chest CT in the initial staging evaluation. Radiology 160:603–605PubMedGoogle Scholar
  12. 12.
    Castellino RA, Hilton S, O’Brien JP, Portlock CS (1996) Non-Hodgkin lymphoma: contribution of chest CT in the initial staging evaluation. Radiology 199:129–132PubMedGoogle Scholar
  13. 13.
    Chen CI, Abraham R, Tsang R, Crump M, Keating A, Stewart AK (2001) Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes. Bone Marrow Transplant 27:177–182CrossRefPubMedGoogle Scholar
  14. 14.
    Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17:1244PubMedGoogle Scholar
  15. 15.
    Choyke PL, Zeman RK, Gootenberg JE, Greenberg JN, Hoffer F, Frank JA (1987) Thymic atrophy and regrowth in response to chemotherapy: CT evaluation. AJR Am J Roentgenol 149:269–272PubMedGoogle Scholar
  16. 16.
    Dai MS, Lee SC, Ho CL, Chen YC, Kao WY, Chao TY (2001) Impact of open lung biopsy for undiagnosed pulmonary infiltrates in patients with hematological malignancies. Am J Hematol 68:87–90CrossRefPubMedGoogle Scholar
  17. 17.
    Dodd GD 3rd, Greenler DP, Confer SR (1992) Thoracic and abdominal manifestations of lymphoma occurring in the immunocompromised patient. Radiol Clin North Am 30:597–610PubMedGoogle Scholar
  18. 18.
    Fassas A, Gojo I, Rapoport A, Cottler-Fox M, Meisenberg B, Papadimitriou JC, Tricot G (2001) Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapy. Bone Marrow Transplant 28:399–403CrossRefPubMedGoogle Scholar
  19. 19.
    Fiche M, Caprons F, Berger F, Galateau F, Cordier JF, Loire R, Diebold J (1995) Primary pulmonary non-Hodgkin’s lymphomas. Histopathology 26:529–537PubMedGoogle Scholar
  20. 20.
    Filly R, Bland N, Castellino RA (1976) Radiographic distribution of intrathoracic disease in previously untreated patients with Hodgkin’s disease and non-Hodgkin’s lymphoma. Radiology 120:277–281PubMedGoogle Scholar
  21. 21.
    Fletcher BD, Kauffman WM, Kaste SC, Winer-Muram HT, Fang L, Chen G, Hudson M (1995) Use of Tl-201 to detect untreated pediatric Hodgkin disease. Radiology 196:851–855PubMedGoogle Scholar
  22. 22.
    Gossot D, Girard P, de Kerviler E, Brice P, Rain JD, Leblanc T, Grunenwald D (2001) Thoracoscopy or CT-guided biopsy for residual intrathoracic masses after treatment of lymphoma. Chest 120:289–294PubMedGoogle Scholar
  23. 23.
    Green DM, Hyland A, Barcos MP, Reynolds JA, Lee RJ, Hall BC, Zevon MA (2000) Second malignant neoplasms after treatment for Hodgkin’s disease in childhood or adolescence. J Clin Oncol 18:1492–1499PubMedGoogle Scholar
  24. 24.
    Hill M, Cunningham D, MacVicar D, Roldan A, Husband J, McCready R, Mansi J, Milan S, Hickish T (1993) Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma. J Clin Oncol 11:2273–2278PubMedGoogle Scholar
  25. 25.
    Hoffmann M, Kletter K, Becherer A, Jager U, Chott A, Raderer M (2003) 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma. Oncology 64:336–340CrossRefPubMedGoogle Scholar
  26. 26.
    Hopper KD, Diehl LF, Lesar M, Barnes M, Granger E, Baumann J (1988) Hodgkin disease: clinical utility of CT in initial staging and treatment. Radiology 169:17–22PubMedGoogle Scholar
  27. 27.
    Janzen DL, Adler BD, Padley SP, Muller NL (1993) Diagnostic success of bronchoscopic biopsy in immunocompromised patients with acute pulmonary disease: predictive value of disease distribution as shown on CT. AJR Am J Roentgenol 160:21–24PubMedGoogle Scholar
  28. 28.
    Kersten MJ, van Oers RH (2001) Management of AIDS-related non-Hodgkin’s lymphomas. Drugs 61:1301–1315PubMedGoogle Scholar
  29. 29.
    King LJ, Padley SP, Wotherspoon AC, Nicholson AG (2000) Pulmonary MALT lymphoma: imaging findings in 24 cases. Eur Radiol 10:1932–1938CrossRefPubMedGoogle Scholar
  30. 30.
    Knowles DM (2003) Etiology and pathogenesis of AIDS-related non-Hodgkin’s lymphoma. Hematol Oncol Clin North Am 17:785–820PubMedGoogle Scholar
  31. 31.
    Lee HJ, Im JG, Goo JM, Kim KW, Choi BI, Chang KH, Han JK, Han MH (2003) Peripheral T-cell lymphoma: spectrum of imaging findings with clinical and pathologic features. Radiographics 23:7–26; discussion 26–28PubMedGoogle Scholar
  32. 32.
    Lee K, Kim Y, Primack S (1997) Imaging of pulmonary lymphomas. AJR Am J Roentgenol 168:339–345PubMedGoogle Scholar
  33. 33.
    Lewis ER, Caskey CI, Fishman EK (1991) Lymphoma of the lung: CT findings in 31 patients. AJR Am J Roentgenol 156:711–714PubMedGoogle Scholar
  34. 34.
    Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana M (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol 7:1630–1636PubMedGoogle Scholar
  35. 35.
    Malatskey A, Fields S, Libson E (1989) CT appearance of primary pleural lymphoma. Comput Med Imaging Graph 13:165–167CrossRefPubMedGoogle Scholar
  36. 36.
    Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ (1996) Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin’s disease: long-term analysis of risk factors and outcome. Blood 87:3625–3632PubMedGoogle Scholar
  37. 37.
    Moog F, Bangerter M, Diederichs CG, Guhlmann A, Kotzerke J, Merkle E, Kolokythas O, Herrmann F, Reske SN (1997) Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Radiology 203:795–800PubMedGoogle Scholar
  38. 38.
    Nakatsuka S, Yao M, Hoshida Y, Yamamoto S, Iuchi K, Aozasa K (2002) Pyothorax-associated lymphoma: a review of 106 cases. J Clin Oncol 20:4255–4260CrossRefPubMedGoogle Scholar
  39. 39.
    Okada F, Ando Y, Kondo Y, Matsumoto S, Maeda T, Mori H (2004) Thoracic CT findings of adult T-cell leukemia or lymphoma. AJR Am J Roentgenol 182:761–767PubMedGoogle Scholar
  40. 40.
    Pagliai F, Rigacci L, Briganti V, Dini C, Castagnoli A, Vaggelli L, Bosi A (2003) PET scan evaluation of thymic mass after autologous peripheral blood stem-cell transplantation in an adult with non-Hodgkin’s lymphoma. Leuk Lymphoma 44:2015–2018CrossRefPubMedGoogle Scholar
  41. 41.
    Press GA, Glazer HS, Wasserman TH, Aronberg DJ, Lee JK, Sagel SS (1985) Thoracic wall involvement by Hodgkin disease and non-Hodgkin lymphoma: CT evaluation. Radiology 157:195–198PubMedGoogle Scholar
  42. 42.
    Quigley M, Brada M, Heron C, Horwich A (1988) Severe lung toxicity with a weekly low dose chemotherapy regimen in patients with non-Hodgkin’s lymphoma. Hematol Oncol 6:319–324PubMedGoogle Scholar
  43. 43.
    Radin AI (1990) Primary pulmonary Hodgkin’s disease. Cancer 65:550–563PubMedGoogle Scholar
  44. 44.
    Rahmouni A, Tempany C, Jones R, Mann R, Yang A, Zerhouni E (1993) Lymphoma: monitoring tumor size and signal intensity with MR imaging. Radiology 188:445–451PubMedGoogle Scholar
  45. 45.
    Rao RD, Robins HI (2001) Non-Hodgkin’s tumor and Pancoast’s syndrome. Oncol Rep 8:165–166PubMedGoogle Scholar
  46. 46.
    Roberts WC, Glancy DL, DeVita VT jr (1968) Heart in malignant lymphoma (Hodgkin’s disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides). A study of 196 autopsy cases. Am J Cardiol 22:85–107CrossRefPubMedGoogle Scholar
  47. 47.
    Rolla G, Bertero MT, Pastena G, Tartaglia N, Corradi F, Casabona R, Motta M, Caligaris-Cappio F (2002) Primary lymphoma of the heart. A case report and review of the literature. Leuk Res 26:117–120CrossRefPubMedGoogle Scholar
  48. 48.
    Sahn SA (1997) Pleural diseases related to metastatic malignancies. Eur Respir J 10:1907–1913PubMedGoogle Scholar
  49. 49.
    Samuels ML, Howe CD, Dodd GD jr, Fuller LM, Shullenberger CC, Leary WL (1961) Endobronchial malignant lymphoma. Report of five cases in adults. Am J Roentgenol Radium Ther Nucl Med 85:87–95PubMedGoogle Scholar
  50. 50.
    Sandrasegaran K, Robinson PJ, Selby P (1994) Staging of lymphoma in adults. Clin Radiol 49:149–161PubMedGoogle Scholar
  51. 51.
    Schmitt-Graff A, Raff T, Rahn W, Stein H (1995) [Primary pulmonary B-cell lymphoma of the MALT type]. Pathologe 16:328–335CrossRefPubMedGoogle Scholar
  52. 52.
    Shaffer K, Smith D, Kirn D, Kaplan W, Canellos G, Mauch P, Shulman LN (1996) Primary mediastinal large-B-cell lymphoma: radiologic findings at presentation. AJR Am J Roentgenol 167:425–430PubMedGoogle Scholar
  53. 53.
    Simonelli C, Spina M, Cinelli R, Talamini R, Tedeschi R, Gloghini A, Vaccher E, Carbone A, Tirelli U (2003) Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. J Clin Oncol 21:3948–3954CrossRefPubMedGoogle Scholar
  54. 54.
    Swerdlow AJ (2003) Epidemiology of Hodgkin’s disease and non-Hodgkin’s lymphoma. Eur J Nucl Med Mol Imaging 30 [suppl 1]:S3–12Google Scholar
  55. 55.
    Swinnen LJ (2000) Diagnosis and treatment of transplant-related lymphoma. Ann Oncol 11 [suppl] 1:45–48Google Scholar
  56. 56.
    Vincent JM, Ng YY, Norton AJ, Armstrong P (1992) CT „angiogram sign“ in primary pulmonary lymphoma. J Comput Assist Tomogr 16:829–831PubMedGoogle Scholar
  57. 57.
    Vose JM, Bierman PJ, Anderson JR, Harrison KA, Dalrymple GV, Byar K, Kessinger A, Armitage JO (1996) Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin’s lymphoma. J Clin Oncol 14:2473–2479PubMedGoogle Scholar
  58. 58.
    Wong PW, Stefanec T, Brown K, White DA (2002) Role of fine-needle aspirates of focal lung lesions in patients with hematologic malignancies. Chest 121:527–532CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  1. 1.Universitätsklinik für RadiodiagnostikAllgemeines Krankenhaus Wien
  2. 2.Universitätsklinik für RadiodiagnostikAllgemeines KrankenhausWien

Personalised recommendations